Company’s 36-month beta value is 1.37.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy”, 1 as “overweight”, 1 as “hold”, and 0 as “sell”.
The public float for ARTL is 0.54M, and currently, short sellers hold a 5.95% ratio of that floaft. The average trading volume of ARTL on July 07, 2025 was 526.45K shares.
ARTL stock’s latest price update
Artelo Biosciences Inc (NASDAQ: ARTL)’s stock price has gone rise by 63.88% in comparison to its previous close of $10.05, however, the company has experienced a 142.56% increase in its stock price over the last five trading days. globenewswire.com reported 2025-07-07 that ART12.11, the Patented CBD:TMP Cocrystal, Demonstrates Potent Antidepressant-Like Activity and Cognitive Benefits Over Leading SSRI
ARTL’s Market Performance
ARTL’s stock has risen by 142.56% in the past week, with a monthly rise of 149.41% and a quarterly rise of 220.00%. The volatility ratio for the week is 39.26% while the volatility levels for the last 30 days are 14.95% for Artelo Biosciences Inc The simple moving average for the past 20 days is 108.65% for ARTL’s stock, with a 148.37% simple moving average for the past 200 days.
Analysts’ Opinion of ARTL
Many brokerage firms have already submitted their reports for ARTL stocks, with Ladenburg Thalmann repeating the rating for ARTL by listing it as a “Buy”. The predicted price for ARTL in the upcoming period, according to Ladenburg Thalmann is $7 based on the research report published on February 12, 2021 of the previous year 2021.
ARTL Trading at 142.77% from the 50-Day Moving Average
After a stumble in the market that brought ARTL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.61% of loss for the given period.
Volatility was left at 14.95%, however, over the last 30 days, the volatility rate increased by 39.26%, as shares surge +131.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +147.25% upper at present.
During the last 5 trading sessions, ARTL rose by +125.04%, which changed the moving average for the period of 200-days by +108.74% in comparison to the 20-day moving average, which settled at $7.83. In addition, Artelo Biosciences Inc saw 107.95% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
N/A, the N/A of Artelo Biosciences Inc, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for ARTL
The total capital return value is set at -0.53%. Equity return is now at value -190.70%, with -140.10% for asset returns.
Based on Artelo Biosciences Inc (ARTL), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -127.11. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -2057.4.
Currently, EBITDA for the company is -10.29 million with net debt to EBITDA at 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.34.
Conclusion
In a nutshell, Artelo Biosciences Inc (ARTL) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
